FDA Adverse Event Malfunction Summary report: N

OMNIPOD DASH¿ INSULIN MANAGEMENT SYSTEM

MDR report key: 15536782 · Received October 4, 2022

Report

Report Number
3004464228-2022-18455
Event Type
Malfunction
Date Received
October 4, 2022
Date of Event
September 16, 2022
Report Date
September 16, 2022
Manufacturer
INSULET CORPORATION
Product Code
LZG
UDI-DI
10385083000114
PMA / PMN Number
K203768
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

ACCORDING TO THE COMPLAINANT THE DEVICE WILL NOT BE RETURNED FOR INVESTIGATION. IT WAS REPORTED THAT THE CANNULA HAD DISLODGED FROM THE INFUSION SITE. THIS CONDITION COULD INTERRUPT INSULIN DELIVERY AND CONTRIBUTE TO HYPERGLYCEMIA. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING COMMUNICATING WITH THE PDM, DEPLOYMENT, DELIVERING FLUID, OCCLUSION DETECTION, AND FREEDOM FROM HAZARD ALARMS.

Additional Manufacturer Narrative · 0

D4: FROM: BLE-I1-529 TO POD-BLE-H1-520 , G4 - PMA/510(K) # FROM: K192659 TO K203768.

Description of Event or Problem · 0

IT WAS REPORTED THE PATIENT'S BLOOD GLUCOSE LEVEL ROSE TO 250 MG/DL WHILE WEARING THE POD BETWEEN 4 AND 24 HOURS. THE POD WAS LEAKING INSULIN FROM THE INFUSION SITE (ABDOMEN), WHEN REMOVED THE POD'S CANNULA WAS FOUND TO BE DISLODGED. NO TREATMENT WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2539846 OMNIPOD DASH¿ INSULIN MANAGEMENT SYSTEM PUMP, INFUSION, INSULIN LZG INSULET CORPORATION PT-000435 PP1K03022211 10385083000114

Patients

Seq Age Sex Outcome Treatment
1 25 YR Male